Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

plenti6-SLC7A11/xCT-V5 Citations (1)

Originally described in: The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P, Zhang Y, Shi J, Li W, Gan B J Biol Chem. 2017 Aug 25;292(34):14240-14249. doi: 10.1074/jbc.M117.798405. Epub 2017 Jun 19. PubMed Journal

Articles Citing plenti6-SLC7A11/xCT-V5

Articles
Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC. Du L, Yang H, Ren Y, Ding Y, Xu Y, Zi X, Liu H, He P. Cell Death Dis. 2023 Nov 3;14(11):716. doi: 10.1038/s41419-023-06238-5. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.